Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
12/21/2007 | CA2653657A1 Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide and starting materials therefor |
12/21/2007 | CA2650263A1 Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
12/20/2007 | US20070293668 Phenylindoles for the treatment of HIV |
12/20/2007 | US20070293558 Ophthalmic Compositions for Treating Ocular Hypertension |
12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
12/20/2007 | US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
12/20/2007 | US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors |
12/20/2007 | US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
12/20/2007 | US20070293470 Carboxamide Spirolactam Cgrp Receptor Antagonists |
12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
12/20/2007 | US20070292485 Polyol ester compounds |
12/20/2007 | DE102006027535A1 Dispersionsfarbstoffe, ihre Herstellung und ihre Verwendung Disperse dyes, to their preparation and their use |
12/19/2007 | EP1867684A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |
12/19/2007 | EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents |
12/19/2007 | EP1866984A1 Composite material, light emitting element and light emitting device |
12/19/2007 | EP1866327A1 Improved process for preparation of highly pure trandolapril |
12/19/2007 | EP1866300A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
12/19/2007 | EP1865949A2 Modulators of atp-binding cassette transporters |
12/19/2007 | EP1778636B1 Oxime ester photoinitiators |
12/19/2007 | EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors |
12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
12/19/2007 | EP1005341B1 Il-8 receptor antagonists |
12/19/2007 | CN101090896A Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
12/19/2007 | CN101090887A Anthracene derivative, light emitting element using the same, and light emitting device using the same |
12/19/2007 | CN101090886A Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid |
12/19/2007 | CN101090883A Substituted hydroxyethylamines |
12/18/2007 | US7309799 Asymmetric reaction of a cyclopropane carboxylic acid, ester, or amide or lactone or lactam with a phthalimide: potassium phthalimide; products are enantiomerically enriched |
12/18/2007 | US7309787 2-Substituted spiro[cyclopropane-1,3'-indolin-2'-ones]: morpholinylphenyl-, piperidinylethylphenyl-, 3-(carboxyethyl)-4-methylpyrrol-2-yl-, pyrazolon-2-yl-, 4-methylimidazol-5-yl-; vascular endothelial growth factor inhibitors; regulate, modulate and/or inhibit abnormal cell proliferation |
12/18/2007 | US7309717 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof |
12/18/2007 | US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia |
12/18/2007 | CA2378087C New process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyclohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamideand its salts |
12/13/2007 | WO2007141283A2 Salts and crystalline salt forms of an 2-indolinone derivative |
12/13/2007 | WO2007127763A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
12/13/2007 | WO2007109211A3 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
12/13/2007 | US20070287825 Constrained cis-diol-borate bioconjugation system |
12/13/2007 | US20070287735 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
12/13/2007 | US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection |
12/13/2007 | US20070287715 e.g.5-(4-tert-Butylphenyl-1-(4-(2-carboxypropan-2-yloxy)phenyl)indole-2-carboxylic acid ; inhibition of the activity of microsomal prostaglandin E synthase-1, 5-lipoxygenase-activating protein (FLAP); respiratory system disorders |
12/13/2007 | US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
12/13/2007 | US20070285004 Arylamine Compound and Organic Electroluminescent Device |
12/13/2007 | CA2653527A1 New salts and crystalline salt forms of an indolinone derivative |
12/12/2007 | EP1864973A1 Process for the preparation of perindopril and salts thereof |
12/12/2007 | EP1863762A1 Indole derivatives and methods of using the same |
12/12/2007 | EP1863464A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
12/12/2007 | CN101087781A Indole derivatives for treating pulmonary tuberculosis |
12/12/2007 | CN101087768A Thrombopoietin activity modulating compounds and methods |
12/12/2007 | CN101087758A Indole derivatives useful as progesterone receptor modulators |
12/12/2007 | CN101085757A Method for forming compound with indole truss by catalytic reaction |
12/12/2007 | CN100354281C Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines |
12/12/2007 | CN100354279C Novel camptothecin derivatives and their preparation process and use |
12/12/2007 | CN100354261C Process for the preparation of 1,1,3,3-tetraalkylisoindolines starting from n-benzylphthalimide |
12/11/2007 | US7307099 Thioredoxin/thioredoxin reductase inhibitors, antiproliferative agents, anticancer agents |
12/11/2007 | US7307098 Indole derivatives and drugs containing the same |
12/11/2007 | US7307088 Substituted anthranilic amide derivatives and methods of use |
12/11/2007 | US7307044 Use as insecticides, fungicides and/or herbicides; e.g. 3-(2-methyl-5-(4-chloro-phenyl)phenyl)-3-chloro-5,5-dimethyl-pyrrolidin-2,4-dione |
12/11/2007 | US7307037 Metallic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors |
12/06/2007 | WO2007140195A2 Methods and systems for increasing production of equilibrium reactions |
12/06/2007 | WO2007139499A1 Compounds for use as a medicament |
12/06/2007 | WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
12/06/2007 | WO2007138611A1 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands |
12/06/2007 | WO2007138282A2 Bi-aryl or aryl-heteroaryl substituted indoles |
12/06/2007 | WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
12/06/2007 | WO2007113680A3 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use |
12/06/2007 | WO2007061768A3 Fluorescent membrane intercalating probes and methods for their use |
12/06/2007 | WO2006110804A3 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules |
12/06/2007 | US20070282111 An aryl compound with an active group is reacted with an amine compound in the presence of a base by means of a catalyst which comprises a palladium compound having a tertiary phosphine group and a phase-transfer catalyst; highly selective and efficient |
12/06/2007 | US20070281934 Indole derivatives as inhibitors of histone deacetylase |
12/06/2007 | CA2653054A1 Methods and systems for increasing production of equilibrium reactions |
12/06/2007 | CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
12/05/2007 | EP1862442A1 Process for oxidation of organic compounds |
12/05/2007 | EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
12/05/2007 | EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
12/05/2007 | EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
12/05/2007 | EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
12/05/2007 | EP1861368A1 Process for the preparation of 2-azabicycloý3.3.0¨octane-3-carboxylic acid derivatives |
12/05/2007 | EP1861367A1 An improved process for the purification of perindopril |
12/05/2007 | EP1861366A2 Mitotic kinesin inhibitors |
12/05/2007 | EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
12/05/2007 | EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
12/05/2007 | EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
12/05/2007 | EP1433479B1 Appetite-stimulating agents and remedies for anorexia |
12/05/2007 | EP1169294B1 Pharmaceutical compounds |
12/05/2007 | CN101084209A Compounds with Kv4 ion channel activity |
12/05/2007 | CN101084190A 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists |
12/05/2007 | CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase |
12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
12/05/2007 | CN100352816C Nociceptin analogs |
12/05/2007 | CN100352805C Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them |
12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
12/04/2007 | US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
12/04/2007 | US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction |
12/04/2007 | US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives |
12/04/2007 | US7304048 For use as anti-inflammatory agents |
12/04/2007 | CA2378082C Process for the preparation of spiro[cis-4-(.beta.-hydroxyethyloxy)cyclohexane-[3h]indol]-2'[1'h]one derivatives |